Searched for
NRT CATEGORY
These large- and mid-cap stocks have seen an improvement in their earnings component; have upside potential of over 33%At least at the index level, the indications are that the bias of the market is now turning bullish. A part of this bullishness, however, c...- JB Chemicals block deal! KKR to likely sell up to 10.2% stake worth Rs 2,578 crore: ReportTau Investment Holdings, a KKR & Co unit, plans to sell a 6.8% stake in JB Chemicals and Pharmaceuticals via a secondary share sale at Rs 1...
- Tailwinds and stronger balance sheets: 5 large-cap stocks with the right mix of two ratios & upside potential of up to 32%A crucial contribution to the growth of a business is the overall size of the market for its product or services. And by market size we mea...
- As smog engulfs the street, essential pills for a healthy of portfolio: 5 pharma stocks with an upside potential of up to 39%Here’s a lesson from history: For a long-term investor, buying in a correcting market is mostly an opportunity. The operative part, of cour...
- Dr Reddy's completes acquisition of Haleon's NRT portfolioDr Reddy's Laboratories has acquired Haleon's global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for GBP 458 million. T...
- Dr Reddy's to buy nicotine replacement brands from UK-based Haleon for $632 millionThe portfolio to be acquired consists of Nicotinell, a global leader in the NRT category with an extensive footprint in over 30 countries s...
- Fundamental tailwinds are a stronger play than volatile markets? 5 Indian pharma stocks with upside potential of up to 31 %There is no doubt that the market is going through a volatile phase and bears are once again telling the street to never write them off. Wi...
- Intent of global acquisitions, has the tide turned for the long term? 5 pharma stocks with upside potential of up to 31 %Just yesterday, there was a news report which suggested that the French government is planning to block the sale of a French generic drug m...
- Fundamental tailwinds are a stronger play than volatile markets? 5 Indian pharma stocks with upside potential of up to 41%There is no doubt that the market is going through a volatile phase and bears are once again telling the street to never write them off. Wi...
- Preparing for volatility is better than suffering it: 5 largecap stocks from different sectors with upside scope of up to 22%Last week two noticeable things happened in the market, first a sharp correction in mid-cap stocks and then on Friday sudden sharp recovery...
- Business and valuation tailwinds to help in outperformance? 5 Indian pharma stocks with upside potential of up to 32%Just before the whole market was consumed by the PSU rally, one sector that came into the limelight after many years of underperformance wa...
- Sectoral tailwinds and stronger balance sheets: 5 largecap stocks with right mix of two important ratiosThere are some sectors where large players have an edge, because the nature of the business is such that there are phases where ability to ...
- Good for all market conditions: 6 largecap stocks with right mix of RoE & RoCEThere is sunshine all around, better than expected GDP numbers, further decline in oil prices, falling US bond yields and clear indication ...
- This Diwali be bullish but selectively: 7 largecap stocks with right mix of RoE & RoCEOnce again bulls have shown that while bears have the right to make a comeback attempt, bulls who have ruled the street for the last three ...
- On a path to recovery; 5 mid-cap pharma stocks with an upside potential up to 41%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in bearish markets. Some of them are mid-sized Ind...
- On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...
- Defensive Bets: 4 midcaps from pharma sector with ‘Buy’ & ‘Strong Buy’ ratings have upside potential of up to 31%As NIFTY gets even more volatile, there are some sectors which are traditionally considered defensive and they tend to get attention when m...
- Why quitting smoking is crucial during COVID-19 pandemicSmoking substantially worsens health outcomes for COVID-19 patients.
- Smokers are more vulnerable to Covid-19Using Nicotine Replacement Therapy can double your chances of quitting smoking (9)
- ITC forays into E-cigarettes segment, will be rolled out pan-India in phasesITC group has forayed into electronic cigarettes to offset shrinking sales of its conventional tobacco cigarettes due to recurrent price in...
Load More
